Xencor, Inc. to Host Fourth Quarter and Full Year 2014 Financial Results Webcast and Conference Call Read more about Xencor, Inc. to Host Fourth Quarter and Full Year 2014 Financial Results Webcast and Conference Call
Xencor Reports XmAb®7195 Top-line Interim Phase 1a Results Showing Rapid Reduction of Serum IgE in Healthy Volunteers Read more about Xencor Reports XmAb®7195 Top-line Interim Phase 1a Results Showing Rapid Reduction of Serum IgE in Healthy Volunteers
Xencor Reports Top-line XmAb®5871 Phase 1b/2a Results Showing Promising Clinical Activity in Rheumatoid Arthritis Read more about Xencor Reports Top-line XmAb®5871 Phase 1b/2a Results Showing Promising Clinical Activity in Rheumatoid Arthritis
Xencor to Webcast Presentations at Two Upcoming Conferences in February Read more about Xencor to Webcast Presentations at Two Upcoming Conferences in February
Xencor and Novo Nordisk Enter Discovery Collaboration Using Xencor's XmAb Bispecific and Immune Inhibitor Technologies Read more about Xencor and Novo Nordisk Enter Discovery Collaboration Using Xencor's XmAb Bispecific and Immune Inhibitor Technologies
MorphoSys and Xencor Publish Final Results from Phase 1/2a Trial of MOR208 (XmAb5574) in CLL/SLL at ASH Annual Meeting Read more about MorphoSys and Xencor Publish Final Results from Phase 1/2a Trial of MOR208 (XmAb5574) in CLL/SLL at ASH Annual Meeting
Xencor Provides Data Updates on XmAb Bispecific Antibody Programs and Announces Presentations at Upcoming American Society of Hematology 2014 Annual Meeting Read more about Xencor Provides Data Updates on XmAb Bispecific Antibody Programs and Announces Presentations at Upcoming American Society of Hematology 2014 Annual Meeting
Xencor to Present at the 25th Annual Oppenheimer & Co. Healthcare Conference Read more about Xencor to Present at the 25th Annual Oppenheimer & Co. Healthcare Conference
Xencor to Present at the 2014 Deutsche Bank BioFEST Conference Read more about Xencor to Present at the 2014 Deutsche Bank BioFEST Conference
Xencor Reports Third Quarter 2014 Financial Results Read more about Xencor Reports Third Quarter 2014 Financial Results
